Cargando…
Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma: FUNCTIONAL AND THERAPEUTIC IMPLICATIONS
CLU (clusterin) is a tumor suppressor gene that we have previously shown to be negatively modulated by the MYCN proto-oncogene, but the mechanism of repression was unclear. Here, we show that MYCN inhibits the expression of CLU by direct interaction with the non-canonical E box sequence CACGCG in th...
Autores principales: | Corvetta, Daisy, Chayka, Olesya, Gherardi, Samuele, D'Acunto, Cosimo W., Cantilena, Sandra, Valli, Emanuele, Piotrowska, Izabela, Perini, Giovanni, Sala, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605651/ https://www.ncbi.nlm.nih.gov/pubmed/23362253 http://dx.doi.org/10.1074/jbc.M113.454280 |
Ejemplares similares
-
Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop
por: Gualdrini, Francesco, et al.
Publicado: (2010) -
Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells
por: Chayka, Olesya, et al.
Publicado: (2015) -
Interdependence of PRC1 and PRC2 for recruitment to Polycomb Response Elements
por: Kahn, Tatyana G., et al.
Publicado: (2016) -
A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma
por: Sottile, Francesco, et al.
Publicado: (2012) -
MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin
por: Gherardi, Samuele, et al.
Publicado: (2013)